Cancer cells experiencing elevated replication stress or harbouring deficiencies in significant DNA repair pathways exhibit heightened susceptibility to ATR inhibitors, thereby enhancing the efficacy of genotoxic agents and promoting tumour cell eradication. Here, ATR is linked to neoplasm.